GSK (GSK) plc announces the commencement of its share buyback program, as announced in its 2024 full year results announcement published on 5 February 2025. The Program will return an additional ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the ...